Handel nachbörslich: 34.95

Spyre Therapeutics Inc (SYRE)

Spyre Therapeutics Inc Aktie (SYRE) Neueste Nachrichten

Spyre Therapeutics Inc (SYRE)

Spyre Therapeutics Inc Aktie (SYRE) Neueste Nachrichten

Spyre Therapeutics (NASDAQ:SYRE) Stock Price Up 5.8% - MarketBeat

Spyre Therapeutics Announces Updated Share Structure - TipRanks

Spyre Therapeutics to Participate in the Jefferies Global Healthcare Conference - PR Newswire

Spyre Therapeutics Inc. (SYRE) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle

Spyre Therapeutics Inc. (SYRE)'s Day in Review: Closing at 32.98, Up by 0.92 – DWinneX - The Dwinnex

Keeping an Eye on Spyre Therapeutics Inc. (SYRE) After Insider Trading Activity – Knox Daily - Knox Daily

Spyre Therapeutics (NASDAQ:SYRE) Stock Price Down 5.5% - MarketBeat

Spyre Therapeutics (NASDAQ:SYRE) Stock Price Down 5.5% - MarketBeat

Spyre Therapeutics, Inc. (NASDAQ:SYRE) Given Average Rating of "Buy" by Analysts - MarketBeat

Spyre Therapeutics, Inc. (NASDAQ:SYRE) Given Average Rating of “Buy” by Analysts - Defense World

Spyre Therapeutics, Inc. (NASDAQ:SYRE) Given Average Rating of "Buy" by Analysts - MarketBeat

Spyre Therapeutics (SYRE) Price Target Increased by 5.00% to 42.84 - MSN

Spyre Therapeutics (SYRE) Price Target Increased by 5.00% to 42.84 - MSN

Spyre Therapeutics names Sandra Milligan to board By Investing.com - Investing.com Canada

Spyre Therapeutics names Sandra Milligan to board By Investing.com - Investing.com Australia

Spyre Therapeutics (NASDAQ:SYRE) Announces Quarterly Earnings Results - MarketBeat

Spyre Therapeutics names Sandra Milligan to board By Investing.com - Investing.com

Spyre Therapeutics names Sandra Milligan to board By Investing.com - Investing.com UK

Spyre Therapeutics Expands Portfolio and Strengthens Leadership - TipRanks.com - TipRanks

Spyre Therapeutics Appoints Accomplished Biopharma Leader Dr. Sandra Milligan to its Board of Directors - PR Newswire

Spyre Therapeutics Appoints Accomplished Biopharma Leader Dr. Sandra Milligan to its Board of Directors - PR Newswire

Spyre Therapeutics, Inc. (NASDAQ:SYRE) Short Interest Update - MarketBeat

Spyre Therapeutics, Inc. (NASDAQ:SYRE) Short Interest Update - MarketBeat

Wells Fargo & Company Boosts Spyre Therapeutics (NASDAQ:SYRE) Price Target to $40.00 - MarketBeat

Spyre Therapeutics (NASDAQ:SYRE) Price Target Increased to $40.00 by Analysts at BTIG Research - Defense World

Spyre Therapeutics (NASDAQ:SYRE) Price Target Increased to $40.00 by Analysts at BTIG Research - Defense World

Spyre Therapeutics (SYRE) Stock Forecast and Price Target 2024 - MarketBeat

Spyre Therapeutics (NASDAQ:SYRE) Shares Gap Up After Analyst Upgrade - Defense World

Spyre Therapeutics (NASDAQ:SYRE) Shares Gap Up After Analyst Upgrade - Defense World

Spyre Therapeutics (NASDAQ:SYRE) Shares Gap Up on Analyst Upgrade - MarketBeat

Spyre Therapeutics (NASDAQ:SYRE) Given New $40.00 Price Target at BTIG Research - MarketBeat

Spyre Therapeutics (NASDAQ:SYRE) Given New $40.00 Price Target at BTIG Research - MarketBeat

Spyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update - PR Newswire

Spyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update - PR Newswire

Spyre Therapeutics (NASDAQ:SYRE) Shares Down 5.1% - MarketBeat

Spyre Therapeutics (NASDAQ:SYRE) Earns Outperform Rating from Analysts at Robert W. Baird - Defense World

Analyzing Spyre Therapeutics (NASDAQ:SYRE) & NexImmune (NASDAQ:NEXI) - Defense World

Spyre Therapeutics Announces Grants of Inducement Awards | | news-journal.com - Longview News-Journal

Spyre Therapeutics (NASDAQ:SYRE) Coverage Initiated at Robert W. Baird - MarketBeat

Spyre Therapeutics Announces Grants of Inducement Awards - PR Newswire

Spyre Therapeutics (NASDAQ:SYRE) Shares Up 6.1% - MarketBeat

Trading Day Review: Spyre Therapeutics Inc. (SYRE) Loses Momentum, Closing at 34.31 – DWinneX - The Dwinnex

Oruka spins out of Paragon with 3 assets, reverse merger and cash - Fierce Biotech

Spyre Therapeutics Secures $180M in Strategic Financial Move - TipRanks.com - TipRanks

Spyre Therapeutics secures $180 million in PIPE deal By Investing.com - Investing.com

NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday

Here's What Could Help Spyre Therapeutics (SYRE) Maintain Its Recent Price Strength

Here's What Could Help Spyre Therapeutics (SYRE) Maintain Its Recent Price Strength - Zacks Investment Research

Spyre Therapeutics Announces Grants of Inducement Awards - PR Newswire

Spyre Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - PR Newswire

Ähnlich wie SYRE